FAQ: Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines episode artwork

EPISODE · May 29, 2025 · 1 MIN

FAQ: Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines

from RhAPPcast

In this expert-led video, Stacey Johnson, NP-C, from the Montana Arthritis Center, breaks down the 2024 ACR Guidelines for Lupus Nephritis and highlights key treatment strategies—including hydroxychloroquine dosing, steroid pulse and taper regimens, and the role of triple therapy. Learn how to tailor treatment for Class III, IV, and V Lupus Nephritis using combinations like mycophenolate, belimumab, calcineurin inhibitors, and low-dose cyclophosphamide.These updated recommendations emphasize precision and safety, focusing on minimizing steroid exposure while maximizing disease control through multi-targeted immune therapy.For more rheumatology insights and clinical updates, visit the Content Rheum at RhAPP.org or download the RhAPP ACE app. #LupusNephritis #ACRGuidelines #RheumatologyEducation #SteroidTapering #Belimumab #Hydroxychloroquine #Mycophenolate #TripleTherapy #AutoimmuneDisease #RhAPP #ContentRheum

Episode metadata supplied by the publisher feed · Published May 29, 2025

Embed this episode

NOW PLAYING

FAQ: Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines

0:00 1:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RhAPPcast?

This episode is 1 minute long.

When was this RhAPPcast episode published?

This episode was published on May 29, 2025.

Can I download this RhAPPcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!